aeterna zentaris inc (AEZ:Toronto)

Executive Profile*

Background*

Mr. Gérard Antoine Limoges, CM, FCPA, FCA, has been the President of Ernst & Young for the Province of Quebec since 1984. Mr. Limoges has vast experience in Accounting, Auditing, Consulting, Mergers and Acquisitions in a wide spectrum of industries. He has a long experience in the areas of accounting, audit, mergers and acquisitions and has worked for clients in a wide range of industries including service companies, retail, communications, transportation, real estate, ... financial institutions, insurance, manufacturing and pulp and paper. Mr. Limoges successively held various positions for 37 years within Ernst & Young including managing partner of the Montreal office in 1979 and served as its Vice-Chairman of Ernst & Young Canada since 1992 and its Deputy Chairman from 1993 to October 1, 1999. He retired from public practice in September 1999. Mr. Limoges practiced for 37 years as a chartered accountant with Ernst & Young. In 1994, Mr. Limoges was retained by the Canadian Government to review the Department of Finance's forecasting accuracy and methods. He serves as the Chairman of The Montreal Institute of Clinical Research. Mr. Limoges serves as Chairman of the Board for Galileo Genomics Inc. and Biogentis Inc. He serves as the Chairman of the Board of Genizon BioSciences Inc. He has been a Corporate Director of Hart Stores Inc., and Hartco Inc. (Hartco Income Fund Hartco Corp.), since 2003. Mr. Limoges serves as a Director of Desjardins Specialized Financial Services Management, a subsidiary of Desjardins Financial Corp. He serves as Director at Desjardins Trust Inc. Mr. Limoges has been Corporate Director at Æterna Zentaris Inc. since December 14, 2004 and Atrium Innovations, Inc. (Formerly Atrium Biotechnologies Inc.) since December 2004. He has been an Independent Director of Taggart Capital Corp. since January 2013. He has been a Corporate Director of eNGENUITY Technologies Inc. since May 2003. He has been Director of Supratek Pharma Inc. since 1999. He serves as Director of Horizon Sciences & Technologies Inc., BNY Trust Company Canada (Bank of New York), MDetro Inc., and Fiducie Desjardins, 3Soft Inc. He is an Independent Trustee, Chairman of Audit Committee, Member of Compensation Committee, Member of Governance Committee, Member of Nominating Committee, and Member of Investment Committee of Homburg Canada Real Estate Investment Trust. He has been Lead Director of Presagis Canada Inc. (a/k/a, Presagis Inc.) since April 2007 and its Corporate Director since May 2003. Mr. Limoges served as an Independent Trustee of Noranda Operating Trust at Noranda Income Fund from February 19, 2007 to September 2010. He served as a Trustee of Alexis Nihon Real Estate Investment Trust from 2002 to April 16, 2007. He served as a Director of Metro Inc. from 2004 to April 2006. Mr. Limoges is active with a number of non-profit organizations, such as École de Technologie Supérieure (engineering faculty of the University of Québec) and the Orchestre Symphonique de Montréal. He serves as the Chairman at Institut De Recherches Cliniques De Montreal. He is a member of the Institute of Corporate Directors, of the Québec Order of Chartered Accountants and of the Canadian Institute of Chartered Accountants. He received the Order of Canada in 2002. He became a Chartered Accountant in 1971 and by profession and obtained the title of Fellow in 1984. Mr. Limoges completed his graduation with Generic Degree from the Management School of Université de Montréal (HEC Montréal) in 1966.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
AEZ:CN	C$2.06 CAD	-0.02

COMPETITOR COMPENSATION